Committed to the development and industrialization of new biological materials.
Zhejiang Youcheng New Material Co., Ltd. is a wholly-owned subsidiary of Zhejiang Youcheng Holding Group. The company was founded on February 2, 2018, with a registered capital of 100 million RMB.
Having introduced in German revolutionary biotechnology and set up the R&D headquarter of lactic acid and poly lactic acid in Hangzhou International Talent Entrepreneurship and Innovation Park (HITEIP), Zhejiang Youcheng New Material Co.,Ltd is committed to the R&D and industrialization of bio-based new materials. In the near future, Youcheng is going to construct a industrialization base of lactic acid and poly lactic acid in Ningbo.
Our goal is to become a leader in biobased new materials industry.
By virtue of the application of the third generation lactic acid technology and the construction of PLA industrial park, Youcheng target on the formalization and intensification of the industry and the optimization of production factors. Through the cost-reduction of PLA to a comparable range of traditional petrol chemical plastics and chemical fibers (PP, PE,PET), we want to boost the transformation, upgrading and innovative development of the downstream industry to formalize an industrial cluster of bio-based eco-friendly materials globally.
Replacing petroleum based plastics and chemical fibers
Polylactic Acid: Representative of Biodegradable Materials
Main Performances of Polylactic Acid
Polylactic acid or PLA, a kind of aliphatic polyester, is nowadays a relatively ideal biodegradable high polymer .
Reduce “white pollution” and greenhouse gases emission; Promote the surface carbon cycle and sustainable regeneration.
Eco-friendly, plant origin, completely biodegradable; Safe since L- lactic acid is an active endogenous substance of the human body, the same as that produced by muscles when doing anaerobic exercises.
Lactic acid technology team
Lactic acid: BluCon Biotech GmbH R & D team under the leadership of Dr.Albrecht Läufer
Zhejiang Yau Cheng group has completed the acquisition of BluCon's overall patented technology and R & D team.
It also established two R & D centers in Cologne, Germany and Hangzhou, Zhejiang.
PLA technology team
PLA: Professor Ren Jie, a leading scientist in the industry, ;eader of the PLA research team of Tongji University.
Dr. Albrecht Läufer
Chairman of the working group on bioengineering between the National Development and Reform Commission of China and the Ministry of Economy and Energy of Germany
Bio Deutschland chairman of the German bioengineering Association
The technology of Blucon has been successfully listed as a key project of the German Ministry of science and technology.
THE CORE TEAM
Director of Nano and Biopolymer Material institute of Material Science and Engineering institute of Tongji University
He has been engaged in preparation, modifacation,
processing and application research of PLA.
Brand positioning: · Global bio based materials suppliers · Global polylactic acid industrial chain solution provider
Development goals: · Establishment of global bio based new materials research center · The world's leading promoters of polylactic acid products
· One of the world's major suppliers of polylactic acid · The world's leading supplier of industrial chain technology
At present, the external environment and national policies have created favorable conditions and opportunities for the rise of the polylactic acid industry. The conditions and opportunities for large-scale construction of lactic acid and polylactic acid projects are relatively and basically ripe.
The company has purchased the mature technology and bacteria that could converse cellulose and hemicellulose into lactic acid, reducing the production cost of lactic acid.
As a company mastering the third generation of lactic acid technology as well as polylactic acid industrialization technology, Youcheng is equipped with abundant polylactic acid application technologies that have reached the commercial level, and the applications of the downstream products have been developed.